Lumbar subcutaneous shunt

National Institute for Clinical Excellence
Record ID 32004000689
Authors' objectives:

This study aims to assess the current evidence on lumbar subcutaneous shunt for the treatment of communicating hydrocephalus (normal pressure hydrocephalus) and benign intracranial hypertension (pseudotumour cerebri).

Authors' recommendations: 1.1 Current evidence on the safety and efficacy of lumbar subcutaneous shunt does not appear adequate for this procedure to be used without special arrangements for consent and for audit or research. 1.2 Clinicians wishing to undertake lumbar subcutaneous shunt should take the following actions. - Inform the clinical governance leads in their Trusts. - Ensure that patients understand the uncertainty about the procedures safety and efficacy and provide them with clear written information. Use of the Institute's Information for the Public is recommended. - Audit and review clinical outcomes of all patients having lumbar subcutaneous shunt. 1.3 Publication of safety and efficacy outcomes will be useful in reducing the current uncertainty. The Institute may review the procedure upon publication of further evidence.
Authors' methods: Overview
Project Status: Completed
Year Published: 2004
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England, United Kingdom
MeSH Terms
  • Cerebrospinal Fluid Shunts
  • Hydrocephalus
  • Intracranial Hypertension
Organisation Name: National Institute for Clinical Excellence
Contact Address: MidCity Place, 71 High Holborn, London WC1V 6NA, UK. Tel: +44 020 7067 5800; Fax: +44 020 7067 5801
Contact Name:
Contact Email:
Copyright: National Institute for Clinical Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.